Tagged 'Johnson & Johnson'

The current issue of the Legal Look reviews a recent bid by Monsanto to pare down the Dewayne Johnson verdict, the adoption of a […]

Blood thinners, or anticoagulants, interfere with the body's clotting mechanisms in an effort to decrease the risks of clot, stroke, embolism and deep vein […]

In this issue of the Legal Look we are examining a judge's order for Monsanto to mediate the latest Roundup lawsuit, the FDA's recent […]

The term "off-label drug use" sounds pretty serious, like it might be risky or illegal, but it's actually very common. Still, if you read […]

Lawyers for Johnson & Johnson settled several talcum powder lawsuits last week, creating abundant speculation about changes to their legal strategy. In keeping with […]

Court documents released Monday indicate Bayer and Johnson and Johnson will settle all federal Xarelto blood thinner lawsuits. The $775 million settlement will be […]

This week, the Legal Look reviews a new Missouri bill that could make it harder for big verdicts in joinedered lawsuits, some lawyer theatrics […]

In this issue of the Legal Look, we are covering a would-be Roundup class action lawsuit in Wisconsin that was denied certification, the expansion […]

Most people know Bayer Corporation as the developer of commercial grade aspirin, but the pharmaceutical giant does a lot more than produce one of […]

In a shocking new expose, internal documents going back more than 40 years show Johnson and Johnson not only knew about carcinogenic asbestos in […]

This week the Legal Look takes on the DePuy hip settlement, the continuation of the FTC's fight against Abbvie's anticompetition practices, a new lawsuit […]

In 2013, the U.S. Food and Drug Administration (FDA) approved the first medication in a new class of drugs to fight type 2 diabetes […]